Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMA provides scientific advice regarding phase III trial of CPP-1X in FAP

Aug. 3, 2011

Encouraging interim results emerge from phase III study of Paclical

Aug. 3, 2011

Bionomics provides update on clinical trials of anticancer candidate BNC-105

Aug. 3, 2011

OncoTherapy Science's anticancer vaccine OTS-102 obtains generic name

Aug. 3, 2011

Alnylam completes phase I ALN-VSP trial

Aug. 3, 2011

Critical Outcome Technologies begins synthesis of AML drug candidates

Aug. 3, 2011

Sanofi discloses novel protein kinase inhibitors

Aug. 3, 2011

MM-398 receives orphan drug status in pancreatic cancer

Aug. 2, 2011

Merck & Co. submits MAA for ridaforolimus in Europe

Aug. 2, 2011

Molecular Response and SuperGen enter translational oncology agreement

Aug. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...